Oral Communication

Efficacy of a platelet-rich plasma treatment in subjects with plantar fasciosis

Dr Francesc PARDO i CAMPS^a, Prof Carmen GARCÍA CARRIÓN^b, Prof Juan Vicente BENEIT MONTESINOS^c, Prof José Luís LÁZARO MARTÍNEZ.^d, Prof Fernando GOMEZ^e, Prof Raquel VALERO^f, Dr Pedro CHANA^e

^a Cirugía Ortopédica i Traumatología, Medicina Bioregenerativa. Hospital Universitario Sant Joan de Reus., ^b Facultad de Enfermeria Fisioterapia y Podologia. Universidad Complutense de Madrid, ^c Clínica Universitaria de Podología, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., ^d Clínica Universitaria de Podología, Universidad Complutense de Madrid., ^e Universidad Antonio de Nebrija, ^fDepartamento de medicina física y Rehabilitación. Facultad de enfermeria Fisioterapiay Podologia. Universidad Complutense

Objectives: To determine the effect of aplatelet-rich plasma (PRP)treatment applied in patients with plantar fasciosis through clinical and quantitative ultrasound measurement, conducted after treatment intervention and during a follow-up period.

Methods: A prospective observational study was conducted in patients diagnosed of PF, treated with PRP ultrasonography guided injection, with a 2-week, 4-week and 3-month follow-up. Eighteen patients with clinical diagnosis of plantar fasciosis who met inclusion criteria .

Results. A decrease of 1.64±1.01mm,(p-value=0.000) in the plantar fascia sagittal thickness was quantified at 2-weeks follow-up, a decrease of 2.01±1.10mm,(p-value=0.000) was quantified at 4-weeks,and a decrease of 2.20±1.02mm,(p-value=0.000) was quantified a 3-months follow-up. All plantar fascia mean reductions were over the Limits of Agreement for plantar fascia ultrasonography for repeated measures. Pain at first steps in the morning was reduced in 4.02±1.94mm at 2-weeks (p-value=0.000), 6±2.54mm at 4-weeks (p-value=0.000) and 7.13±2.37mm at 3-months (p-value=0.000) follow-up. Pain on return to weight-bearing following rest was reduced in 3.66±2.32mm at 2-weeks (p-value=0.000), 4.94±2.09mm at 4-weeks (p-value=0.000) and 6.30±2.34mm at 3-months (p-value=0.000) follow-up.

Conclusion: Preliminary results suggest that PRP is a safeandeffective therapeutic approach to reduce plantar fascia sagittal thickness following the L.O.A for repeated measurements in patients with PF, correlated with an improvement of pain.

Keywords : Key words: Plantar fasciitis (fasciosis), PRP, Ultrasonography, clinical outcomes.

Més informació a la web

 

http://drpardocamps.com/wp-content/subidas/sofmer2014_eposter_P111.pdf